Vitamin D deficiency and cancer: Is there a hidden connection?

We tend to notice vitamin D only when bones ache, or fatigue drags us down. But beneath that subtle tiredness may lie something more: mounting evidence that low vitamin D levels may quietly raise cancer risk and even influence survival. This isn't about miracle cures or dramatic headlines, it’s about how daily lifestyle, sun exposure, diet, and biology intersect in ways most of us rarely think about.

World Alzheimer's Day 2025: The first signs families often miss

Cancer researchers are increasingly examining how deficiencies, including vitamin D, and everyday lifestyle choices may influence the disease. Let us understand how Vitamin D is affecting our body

Vitamin D isn’t just a simple vitamin, it’s actually a group of fat-soluble compounds that the body can turn into an active hormone called calcitriol. Its best-known job is helping us absorb calcium and phosphorus for strong bones, but it also supports muscle and nerve function, strengthens the immune system, reduces inflammation, and helps regulate how cells grow. The body uses vitamin D by binding it to special receptors found in many tissues. In lab studies, this process has been shown to affect how cells mature, how they self-destruct when damaged, how blood vessels form, and other changes linked to tumor growth.

Health experts set vitamin D intake goals based on the idea that people get only a little sun. For adults aged 19–70, the daily recommended amount is 15 µg (600 IU), and for those over 71 it is 20 µg (800 IU). Babies need about 10 µg (400 IU) per day. The safe upper limit for older children and adults is about 100 µg (4,000 IU) daily. Blood levels below 30 nmol/L (12 ng/mL) are seen as deficient, while 50 nmol/L (20 ng/mL) or higher is considered enough for bone and overall health.

Early population studies observed lower cancer incidence and mortality in sunnier (southern) latitudes, prompting a hypothesis that vitamin D, produced in sun-exposed skin, might mediate those patterns. Lab studies supported the idea: in cells and animal tumors, vitamin D and its active form changed how cells grew, encouraged them to mature normally, increased cell death when needed, and reduced blood vessel growth and spread of cancer. These effects suggested that vitamin D might slow down the rate of tumor growth or progression. Because of this mix of ecological, population, and lab evidence, researchers moved on to long-term observational studies and clinical trials to see if higher vitamin D levels could lower cancer risk or improve survival.

Most research has shown that vitamin D supplements, with or without calcium, do not reduce the risk of developing cancer overall or of developing specific cancers. Further, a report by United States Preventive Serves Task Force (USPSTF) found little or no benefit for vitamin D in preventing cancer, cardiovascular disease, and death. The VITAL trial (≈25,000 participants, 2000 IU/day) found no reduction in overall invasive cancer or in breast, prostate or colorectal cancer incidence over about five years. The ViDA trial in New Zealand and other large trials likewise reported no effect on overall cancer incidence.

Current research shows that taking vitamin D should not be promoted as a general way to prevent cancer. Researchers still don’t know if people with serious deficiency benefit more, if daily doses work differently than large occasional doses, or if certain cancers or groups of people see bigger effects. New studies focusing on deficient groups may give clearer answers. For now, experts recommend vitamin D mainly for bone and overall health, not as a cancer cure.